At Phico, we are developing a unique antibiotic technology to address one the most urgent challenges facing medicine today – how to destroy multi-drug resistant bacteria, the so-called “superbugs”.
Our patented platform utilises an antibacterial protein, SASP to inactivate bacterial DNA and cause rapid destruction of target bacteria. With a number of advantages over conventional antibiotic classes, SASPject™ could form the basis for a new generation of antibiotics to overcome antimicrobial resistance.
Watch our animation to discover how our technology works: https://www.youtube.com/channel/UCjPndK0F9ufmEy9fBQFTsUg
Twitter: @Phicotx
Youtube: Phico Therapeutics Ltd
Our patented platform utilises an antibacterial protein, SASP to inactivate bacterial DNA and cause rapid destruction of target bacteria. With a number of advantages over conventional antibiotic classes, SASPject™ could form the basis for a new generation of antibiotics to overcome antimicrobial resistance.
Watch our animation to discover how our technology works: https://www.youtube.com/channel/UCjPndK0F9ufmEy9fBQFTsUg
Twitter: @Phicotx
Youtube: Phico Therapeutics Ltd
Location: United Kingdom, England, Bourn
Employees: 11-50
Total raised: $14.78M
Founded date: 2000
Investors 5
| Date | Name | Website |
| - | Winton Ven... | winton.com |
| - | Greenwood ... | gwcinvesto... |
| - | ET Capital | etcapital.... |
| 15.05.2021 | BGF Ventur... | bgf.co.uk |
| - | CARB-X | carb-x.org |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 11.05.2021 | - | $9.9M | BGF Ventur... |
| 06.08.2018 | - | $1.84M | - |
| 24.08.2016 | - | $3.04M | - |
Mentions in press and media 5
| Date | Title | Description |
| 01.02.2022 | Phico Therapeutics establishes Scientific Advisory Board | Phico Therapeutics establishes Scientific Advisory Board 01-02-2022 SAB will provide scientific oversight and strategic advice to support the progression Phico’s engineered phage antibacterial therapy, SASPject, through clinical trials. CAM... |
| 11.05.2021 | Phico Therapeutics raises £7 million investment | Phico Therapeutics raises £7 million investment 11-05-2021 Phico Therapeutics Ltd, a biotechnology company developing engineered phage technology as the basis of a new generation of antibiotics to overcome antibacterial resistance, today an... |
| 01.08.2018 | Phico Therapeutics Receives £1.4M Innovate UK Funding for Antibacterial Therapy Project | Phico Therapeutics Ltd, a Cambridge, UK-based biotechnology company, received £1.4m (approx. $1.87m) in funding. Innovate UK provided the award. The company will use the funds for the development of a Pseudomonas aeruginosa targeted therape... |
| 24.08.2016 | GWC members invest £2.3m in Phico Therapeutics | GWC members invest £2.3m in Phico Therapeutics. We are pleased to announce that GWC led the £2.5m round and introduced significant UK family offices to this exciting opportunity. |
| - | BGF leads £7m investment round into Phico Therapeutics | Cambridge based biotechnology company, Phico Therapeutics (‘Phico’), announced today it has received £7 million in funding from a consortium of investors. BGF led the round with a £3 million investment, while a further £4 million was recei... |